News
FDA approves Novavax COVID-19 shot but with unusual restrictions
WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization from FDA for use in anyone 12 and older.
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Novavax today announced that the US Food and Drug Administration (FDA) has approved full licensure for its COVID-19 vaccine, ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback